Pharmaceutically acceptable alendronate salts in amorphous form

Details for Australian Patent Application No. 2002334200 (hide)

Owner Cipla Limited

Inventors Rao, Dhanmaraj Ramachandra; Kankan, Rajendra Narayanrao; Hamied, Yusuf Khwaja

Agent Griffith Hack

Pub. Number AU-B-2002334200

PCT Number PCT/GB02/04730

PCT Pub. Number WO2003/033508

Priority 0125081.0 18.10.01 GB

Filing date 18 October 2002

Wipo publication date 28 April 2003

Acceptance publication date 3 April 2008

International Classifications

A61K 31/663 (2006.01)

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 19/08 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

C07F 9/38 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

13 February 2003 Complete Application Filed

  Priority application(s): 0125081.0 18.10.01 GB

3 July 2003 Application Open to Public Inspection

  Published as AU-B-2002334200

3 November 2005 Amendment Made

  The nature of the amendment is: Amend the name of the applicant Cipla Ltd to Cipla Limited

3 April 2008 Application Accepted

  Published as AU-B-2002334200

31 July 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002334201-APPARATUS AND METHOD FOR DELIVERING FLUENT COLOURANT MATERIAL

2002334199-MULTIMERIC PROTEINS